PD39-02 FOCAL THERAPY CONSENSUS: RECOMMENDATIONS OF A DELPHI INITIATIVE TO CONSOLIDATE PARTIAL GLAND ABLATION IN LOCALIZED PROSTATE CANCER
Lara Rodríguez‐Sánchez(Institute Mutualiste Montsouris), Theo M. de Reijke(Amsterdam University Medical Centers), Phillip D. Stricker(Prostate Cancer Foundation of Australia), Fernando J. Bianco, George R. Schade(University of Washington), Anna Lantz(Mount Sinai Hospital), Peter Ka‐Fung Chiu(Chinese University of Hong Kong), Petr Macek(Institute Mutualiste Montsouris), Pilar Laguna(Istanbul Medipol University), Aiman Haider(University College London Hospitals NHS Foundation Trust), Éva Compérat(Vienna General Hospital), Rafael Sánchez-Salas(McGill University), G. Fiard(Centre Hospitalier Universitaire de Grenoble), Robert E. Reiter(University of California, Los Angeles), Luca Lunelli, Alejandro Rodríguez(Good Samaritan Medical Center), Alberto Bossi(Institut Gustave Roussy), José L. Domínguez-Escrig(Fundación Instituto Valenciano de Oncología), Marc Emberton, Anita Mitra(University College Hospital), Georg Salomon
Cited by 0
Related Papers
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
|European Urology|2020|2.2k
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
|European Urology|2016|1.5k
Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)
|The Lancet|2005|1.1k
Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)
|The Lancet|2012|864
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694